Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Bibliographic Details
Main Authors:	Glynne-Jones, R., Hava, N., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Gaya, A., Wasan, H., Moran, B., Melcher, L., MacDonald, A., Osborne, M., Beare, S., Jitlal, M., Lopes, A., Hall, M., West, N., Quirke, P., Wong, Wai-Lup, Harrison, M.
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619031/

id	pubmed-4619031
recordtype	oai_dc
spelling	pubmed-46190312015-10-25 Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum Glynne-Jones, R. Hava, N. Goh, V. Bosompem, S. Bridgewater, J. Chau, I. Gaya, A. Wasan, H. Moran, B. Melcher, L. MacDonald, A. Osborne, M. Beare, S. Jitlal, M. Lopes, A. Hall, M. West, N. Quirke, P. Wong, Wai-Lup Harrison, M. Study Protocol BioMed Central 2015-10-23 /pmc/articles/PMC4619031/ /pubmed/26493588 http://dx.doi.org/10.1186/s12885-015-1764-1 Text en © Glynne-Jones et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Glynne-Jones, R. Hava, N. Goh, V. Bosompem, S. Bridgewater, J. Chau, I. Gaya, A. Wasan, H. Moran, B. Melcher, L. MacDonald, A. Osborne, M. Beare, S. Jitlal, M. Lopes, A. Hall, M. West, N. Quirke, P. Wong, Wai-Lup Harrison, M.
spellingShingle	Glynne-Jones, R. Hava, N. Goh, V. Bosompem, S. Bridgewater, J. Chau, I. Gaya, A. Wasan, H. Moran, B. Melcher, L. MacDonald, A. Osborne, M. Beare, S. Jitlal, M. Lopes, A. Hall, M. West, N. Quirke, P. Wong, Wai-Lup Harrison, M. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
author_facet	Glynne-Jones, R. Hava, N. Goh, V. Bosompem, S. Bridgewater, J. Chau, I. Gaya, A. Wasan, H. Moran, B. Melcher, L. MacDonald, A. Osborne, M. Beare, S. Jitlal, M. Lopes, A. Hall, M. West, N. Quirke, P. Wong, Wai-Lup Harrison, M.
author_sort	Glynne-Jones, R.
title	Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_short	Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_full	Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_fullStr	Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_full_unstemmed	Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
title_sort	bevacizumab and combination chemotherapy in rectal cancer until surgery (bacchus): a phase ii, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum
description
publisher	BioMed Central
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619031/
_version_	1613492389097242624

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum

Similar Items